Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Pulmonx CorpLUNG · Entity 2359 | Chief Commercial Officer | September 01, 2026 | September 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Pulmonx Corp
Report date September 01, 2026 · Filed September 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 449,832 |
Ending reported balance
After 2026-09-01 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-09-01 · Sale · Disposed 2,213 · Balance 455,498 F1: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on March 2, 2026. Row 2 · 2026-09-01 · Sale · Disposed 2,390 · Balance 453,108 F2: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 3, 2025. Row 3 · 2026-09-01 · Sale · Disposed 1,530 · Balance 451,578 F3: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2024. Row 4 · 2026-09-01 · Sale · Disposed 1,746 · Balance 449,832 F4: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on March 2, 2026.
F2: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 3, 2025.
F3: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2024.
F4: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 01, 2026 Filed Sep 3, 2026 22:17 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 1,746 | $2.26 | $3,945.96 |
DisclosureSEC source: 0001804146-26-000004 · form4-09032026_100924.xml · nonDerivative · entry 4 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 449,832 F4 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 22:17 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 1,530 | $2.26 | $3,457.80 |
DisclosureSEC source: 0001804146-26-000004 · form4-09032026_100924.xml · nonDerivative · entry 3 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 451,578 F3 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2024. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 22:17 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 2,390 | $2.26 | $5,401.40 |
DisclosureSEC source: 0001804146-26-000004 · form4-09032026_100924.xml · nonDerivative · entry 2 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 453,108 F2 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 3, 2025. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 22:17 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 2,213 | $2.26 | $5,001.38 |
DisclosureSEC source: 0001804146-26-000004 · form4-09032026_100924.xml · nonDerivative · entry 1 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 455,498 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on March 2, 2026. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:16 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 2,254 | $1.54 | $3,471.16 |
DisclosureSEC source: 0001804146-26-000002 · form4-06032026_080635.xml · nonDerivative · entry 4 Rose Geoffrey Beran · CIK 0001804146 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 457,711 F4 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 2, 2026. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:16 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 2,434 | $1.54 | $3,748.36 |
DisclosureSEC source: 0001804146-26-000002 · form4-06032026_080635.xml · nonDerivative · entry 3 Rose Geoffrey Beran · CIK 0001804146 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 459,965 F3 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 3, 2025. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:16 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 1,557 | $1.54 | $2,397.78 |
DisclosureSEC source: 0001804146-26-000002 · form4-06032026_080635.xml · nonDerivative · entry 2 Rose Geoffrey Beran · CIK 0001804146 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 462,399 F2 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2024. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:16 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 1,778 | $1.54 | $2,738.12 |
DisclosureSEC source: 0001804146-26-000002 · form4-06032026_080635.xml · nonDerivative · entry 1 Rose Geoffrey Beran · CIK 0001804146 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 463,956 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on March 1, 2023. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 00:04 UTC | Pulmonx Corp LUNG · Entity 2359 | GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001804146-26-000001 · form4-03052026_120358.xml · nonDerivative · entry 5 Rose Geoffrey Beran · CIK 0001804146 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 465,734 F5 · shares: Represents grant of RSUs payable solely in common stock of the Issuer that vest in equal quarterly installments over the four-year period from the grant date of March 2, 2026. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 00:04 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 2,911 | $1.43 | $4,162.73 |
DisclosureSEC source: 0001804146-26-000001 · form4-03052026_120358.xml · nonDerivative · entry 4 Rose Geoffrey Beran · CIK 0001804146 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 365,734 F4 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 3, 2025. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 00:04 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 1,861 | $1.43 | $2,661.23 |
DisclosureSEC source: 0001804146-26-000001 · form4-03052026_120358.xml · nonDerivative · entry 3 Rose Geoffrey Beran · CIK 0001804146 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 368,645 F3 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2024. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 00:04 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 2,125 | $1.43 | $3,038.75 |
DisclosureSEC source: 0001804146-26-000001 · form4-03052026_120358.xml · nonDerivative · entry 2 Rose Geoffrey Beran · CIK 0001804146 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 370,506 F2 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 00:04 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 835 | $1.43 | $1,194.05 |
DisclosureSEC source: 0001804146-26-000001 · form4-03052026_120358.xml · nonDerivative · entry 1 Rose Geoffrey Beran · CIK 0001804146 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 372,631 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on March 1, 2022. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 00:48 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 2,379 | $1.57 | $3,735.03 |
DisclosureSEC source: 0001804146-25-000004 · form4-12042025_121203.xml · nonDerivative · entry 4 Rose Geoffrey Beran · CIK 0001804146 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 373,466 F4 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 3, 2025. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 00:48 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 1,522 | $1.57 | $2,389.54 |
DisclosureSEC source: 0001804146-25-000004 · form4-12042025_121203.xml · nonDerivative · entry 3 Rose Geoffrey Beran · CIK 0001804146 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 375,845 F3 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2024. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 00:48 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 1,738 | $1.57 | $2,728.66 |
DisclosureSEC source: 0001804146-25-000004 · form4-12042025_121203.xml · nonDerivative · entry 2 Rose Geoffrey Beran · CIK 0001804146 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 377,367 F2 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023. Read SEC document |
| December 01, 2025 Filed Dec 4, 2025 00:48 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 683 | $1.57 | $1,072.31 |
DisclosureSEC source: 0001804146-25-000004 · form4-12042025_121203.xml · nonDerivative · entry 1 Rose Geoffrey Beran · CIK 0001804146 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 379,105 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on March 1, 2022. Read SEC document |
| September 02, 2025 Filed Sep 3, 2025 21:10 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 2,462 | $1.60 | $3,939.20 |
DisclosureSEC source: 0001415889-25-023572 · form4-09032025_090934.xml · nonDerivative · entry 4 Rose Geoffrey Beran · CIK 0001804146 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 379,788 F4 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 3, 2025. Read SEC document |
| September 02, 2025 Filed Sep 3, 2025 21:10 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 1,575 | $1.60 | $2,520.00 |
DisclosureSEC source: 0001415889-25-023572 · form4-09032025_090934.xml · nonDerivative · entry 3 Rose Geoffrey Beran · CIK 0001804146 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 382,250 F3 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2024. Read SEC document |
| September 02, 2025 Filed Sep 3, 2025 21:10 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 1,799 | $1.60 | $2,878.40 |
DisclosureSEC source: 0001415889-25-023572 · form4-09032025_090934.xml · nonDerivative · entry 2 Rose Geoffrey Beran · CIK 0001804146 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 383,825 F2 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023. Read SEC document |
| September 02, 2025 Filed Sep 3, 2025 21:10 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 707 | $1.60 | $1,131.20 |
DisclosureSEC source: 0001415889-25-023572 · form4-09032025_090934.xml · nonDerivative · entry 1 Rose Geoffrey Beran · CIK 0001804146 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 385,624 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on March 1, 2022. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 22:04 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 2,463 | $3.13 | $7,709.19 |
DisclosureSEC source: 0001415889-25-015643 · form4-06042025_100619.xml · nonDerivative · entry 5 Rose Geoffrey Beran · CIK 0001804146 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 386,331 F5 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 3, 2025. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 22:04 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 1,576 | $3.13 | $4,932.88 |
DisclosureSEC source: 0001415889-25-015643 · form4-06042025_100619.xml · nonDerivative · entry 4 Rose Geoffrey Beran · CIK 0001804146 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 388,794 F4 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2024. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 22:04 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 1,799 | $3.13 | $5,630.87 |
DisclosureSEC source: 0001415889-25-015643 · form4-06042025_100619.xml · nonDerivative · entry 3 Rose Geoffrey Beran · CIK 0001804146 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 390,370 F3 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 22:04 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 708 | $3.13 | $2,216.04 |
DisclosureSEC source: 0001415889-25-015643 · form4-06042025_100619.xml · nonDerivative · entry 2 Rose Geoffrey Beran · CIK 0001804146 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 392,169 F2 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2022. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 22:04 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 401 | $3.14 | $1,259.14 |
DisclosureSEC source: 0001415889-25-015643 · form4-06042025_100619.xml · nonDerivative · entry 1 Rose Geoffrey Beran · CIK 0001804146 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 392,877 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on June 1, 2021. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 23:02 UTC | Pulmonx Corp LUNG · Entity 2359 | GrantCommon Stock | 108,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-007034 · form4-03052025_110324.xml · nonDerivative · entry 5 Rose Geoffrey Beran · CIK 0001804146 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 393,278 F5 · shares: Represents grant of RSUs payable solely in common stock of the Issuer that vest in equal quarterly installments over the four-year period from the grant date of March 3, 2025. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 23:02 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 2,017 | $7.12 | $14,361.04 |
DisclosureSEC source: 0001415889-25-007034 · form4-03052025_110324.xml · nonDerivative · entry 4 Rose Geoffrey Beran · CIK 0001804146 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 285,278 F4 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2024. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 23:02 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 2,327 | $7.14 | $16,614.78 |
DisclosureSEC source: 0001415889-25-007034 · form4-03052025_110324.xml · nonDerivative · entry 3 Rose Geoffrey Beran · CIK 0001804146 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 287,295 F3 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 23:02 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 915 | $7.12 | $6,514.80 |
DisclosureSEC source: 0001415889-25-007034 · form4-03052025_110324.xml · nonDerivative · entry 2 Rose Geoffrey Beran · CIK 0001804146 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 289,622 F2 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2022. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 23:02 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 520 | $7.12 | $3,702.40 |
DisclosureSEC source: 0001415889-25-007034 · form4-03052025_110324.xml · nonDerivative · entry 1 Rose Geoffrey Beran · CIK 0001804146 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 290,537 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on June 1, 2021. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 23:18 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 1,538 | $6.18 | $9,504.84 |
DisclosureSEC source: 0001415889-24-028319 · form4-12042024_111238.xml · nonDerivative · entry 4 Rose Geoffrey Beran · CIK 0001804146 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 291,057 F4 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2024. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 23:18 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 1,756 | $6.19 | $10,869.64 |
DisclosureSEC source: 0001415889-24-028319 · form4-12042024_111238.xml · nonDerivative · entry 3 Rose Geoffrey Beran · CIK 0001804146 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 292,595 F3 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 23:18 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 690 | $6.18 | $4,264.20 |
DisclosureSEC source: 0001415889-24-028319 · form4-12042024_111238.xml · nonDerivative · entry 2 Rose Geoffrey Beran · CIK 0001804146 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 294,351 F2 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2022. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 23:18 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 392 | $6.19 | $2,426.48 |
DisclosureSEC source: 0001415889-24-028319 · form4-12042024_111238.xml · nonDerivative · entry 1 Rose Geoffrey Beran · CIK 0001804146 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 295,041 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on June 1, 2021. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 22:10 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 1,610 | $6.71 | $10,803.10 |
DisclosureSEC source: 0001415889-24-022972 · form4-09052024_100923.xml · nonDerivative · entry 4 Rose Geoffrey Beran · CIK 0001804146 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 295,433 F4 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2024. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 22:10 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 1,842 | $6.69 | $12,322.98 |
DisclosureSEC source: 0001415889-24-022972 · form4-09052024_100923.xml · nonDerivative · entry 3 Rose Geoffrey Beran · CIK 0001804146 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 297,043 F3 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 22:10 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 724 | $6.69 | $4,843.56 |
DisclosureSEC source: 0001415889-24-022972 · form4-09052024_100923.xml · nonDerivative · entry 2 Rose Geoffrey Beran · CIK 0001804146 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 298,885 F2 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2022. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 22:10 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 410 | $6.71 | $2,751.10 |
DisclosureSEC source: 0001415889-24-022972 · form4-09052024_100923.xml · nonDerivative · entry 1 Rose Geoffrey Beran · CIK 0001804146 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 299,609 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on June 1, 2021. Read SEC document |
| June 24, 2024 Filed Jun 26, 2024 22:07 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 1,184 | $6.16 | $7,293.44 |
DisclosureSEC source: 0001415889-24-018262 · form4-06262024_100621.xml · nonDerivative · entry 1 Rose Geoffrey Beran · CIK 0001804146 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 300,019 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 24, 2023. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 21:58 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 1,510 | $6.97 | $10,524.70 |
DisclosureSEC source: 0001415889-24-015632 · form4-06052024_090634.xml · nonDerivative · entry 4 Rose Geoffrey Beran · CIK 0001804146 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 301,203 F4 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2024. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 21:58 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 1,724 | $6.97 | $12,016.28 |
DisclosureSEC source: 0001415889-24-015632 · form4-06052024_090634.xml · nonDerivative · entry 3 Rose Geoffrey Beran · CIK 0001804146 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 302,713 F3 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 21:58 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 678 | $6.97 | $4,725.66 |
DisclosureSEC source: 0001415889-24-015632 · form4-06052024_090634.xml · nonDerivative · entry 2 Rose Geoffrey Beran · CIK 0001804146 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 304,437 F2 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2022. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 21:58 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 385 | $6.97 | $2,683.45 |
DisclosureSEC source: 0001415889-24-015632 · form4-06052024_090634.xml · nonDerivative · entry 1 Rose Geoffrey Beran · CIK 0001804146 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 305,115 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on June 1, 2021. Read SEC document |
| May 22, 2024 Filed May 23, 2024 22:07 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 1,184 | $8.71 | $10,312.64 |
DisclosureSEC source: 0001415889-24-014373 · form4-05232024_100518.xml · nonDerivative · entry 1 Rose Geoffrey Beran · CIK 0001804146 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 305,500 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 24, 2023. Read SEC document |
| April 22, 2024 Filed Apr 24, 2024 22:14 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 1,184 | $7.49 | $8,868.16 |
DisclosureSEC source: 0001415889-24-011468 · form4-04242024_100440.xml · nonDerivative · entry 1 Rose Geoffrey Beran · CIK 0001804146 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 306,684 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 24, 2023. Read SEC document |
| March 22, 2024 Filed Mar 26, 2024 21:53 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 1,184 | $9.36 | $11,082.24 |
DisclosureSEC source: 0001415889-24-009142 · form4-03262024_090353.xml · nonDerivative · entry 1 Rose Geoffrey Beran · CIK 0001804146 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 307,868 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 24, 2023. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 23:22 UTC | Pulmonx Corp LUNG · Entity 2359 | GrantEmployee Stock Option (right to buy) · Derivative | 69,100 | $0.00 Strike: $9.30 | $0.00 |
DisclosureSEC source: 0001415889-24-006846 · form4-03052024_110331.xml · derivative · entry 5 Rose Geoffrey Beran · CIK 0001804146 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,100 Underlying: Common Stock · 69,100 shares Expires 2034-02-28 F5 · derivative.exercise_date: The shares subject to the option vest in 48 equal monthly installments beginning on March 1, 2024. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 23:22 UTC | Pulmonx Corp LUNG · Entity 2359 | GrantCommon Stock | 34,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-006846 · form4-03052024_110331.xml · nonDerivative · entry 4 Rose Geoffrey Beran · CIK 0001804146 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 274,452 F4 · shares: Represents grant of RSUs payable solely in common stock of the Issuer that vest over four years in equal quarterly installments beginning on March 1, 2024. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 23:22 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 1,916 | $9.06 | $17,358.96 |
DisclosureSEC source: 0001415889-24-006846 · form4-03052024_110331.xml · nonDerivative · entry 3 Rose Geoffrey Beran · CIK 0001804146 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 239,952 F3 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.